oligonucleotides (Gilead/Glaxo)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameoligonucleotides (Gilead/Glaxo)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionNucleic acid metabolism modulatorsProtein synthesis inhibitorsAntisense oligonucleotide inhibitors +[4] 
TargetsUpdating
Therapy Area/IndicationsNeoplasmsVirus DiseasesHIV Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Sciences IncGlaxo Group Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasmsVirus DiseasesHIV Infections +[4] 

Other Information

ATC CodeN/A
Related LinksN/A